9.55 USD
↘ 0.20 (2.05%)LIVE (AS OF 02:24 PM EST)
Bicara Therapeutics Inc. Common Stock (BCAX) is currently trading at $9.55. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest BCAX is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Nov 16, 2026.